Ms. Bruns is an experienced patient advocate, an influencer within the rare disease community and a former rare disease nonprofit leader. Using strategic and operational leadership, she provides synergy between Clinical Operations and Patient Advocacy with a focus on building the framework for pipeline assets. Her direct understanding of the unique needs of the rare community provide valuable insights to the innovation teams. Ms. Bruns’ dedication to supporting families and rare disease organizations ensure that patient perspective is included in all areas of drug development.
